Full-Field Ablative Resurfacing: Is the Pendulum Swinging Back?
Joel Cohen, MDAccording to ODAC Vice-Chair Dr. Joel Cohen, Director of AboutSkin Dermatology (Greenwood Village and Lone Tree, Colorado),  and Associate Clinical Professor at the University of California at Irvine, the pendulum is swinging back to heavy resurfacing in areas such as around the mouth and around the eyes that really need it. He uses full-field erbium resurfacing and shares why this is the way to …
Joel Cohen, MD
Intralesional Triamcinolone Acetonide in the Treatment of Traction Alopecia
In this case series, JDD authors evaluate the efficacy and safety of intralesional triamcinolone acetonide injections (ILK) when used with topical minoxidil in the management of traction alopecia in 6 African American women. Background Traction alopecia (TA) is a form of hair loss secondary to repetitive and/or prolonged tension to a hair follicle over an extended period of time. This typically …
Managing Acne Among Individuals Receiving Masculinizing Hormone Therapy (MHT)
MHT in Transgender MenMasculinizing hormone therapy (MHT) represents a common therapeutic intervention for transgender men (female-to-male) and other gender diverse individuals. MHT typically involves the use of one of several forms of parenteral testosterone (e.g. gel, patch, intramuscular, pellet).1 The goal of MHT is to help develop masculine secondary sex characteristics and/or suppress feminine characteristics in …
MHT in Transgender Men
What’s New in Treatments for Hair Loss
Hair Loss TreatmentsNext Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, is excited to share a new video series where dermatology key opinion leaders share important updates and pearls on a variety of medical, surgical, and aesthetic dermatology topics. First up is Dr. Amy McMichael, Professor and Chair of Dermatology at the Wake Forest University School of Medicine, sharing …
Hair Loss Treatments
Lichen Myxedematosus
Lichen MyxedematosusLichen myxedematosus (LM) is an idiopathic cutaneous mucinosis, commonly described as localized scleromyxedema. In contrast to scleromyxedema, there is typically no systemic involvement. Treatment options are limited and spontaneous resolution has been reported. JDD authors Amaris Geisler BS, Mojgan Hosseinipour DO, Nikki S. Vyas MD, Robert Phelps MD, Charles Gropper MD, and Cindy Hoffman DO p …
Lichen Myxedematosus
error

Enjoy this blog? Please spread the word :)